Publikationen von HJ Staab

Attiyeh, F.; Ellis, H.; Killingback, M.; Oates, G.; Schofield, P.; Staab, H.; Steele Jr, G.; Sugarbaker, P.: Symposium: The management of recurrent colorectal cancer. International Journal of Colorectal Disease 1 (3), S. 133 - 151 (1986)

Bogenschütz, O.; Brümmendorf, T.; Staab, H.; Anderer, F.; Kieninger, G.: Prognostic value of preoperative serum CEA level compared to clinical staging. IV. Histological grading and tumor type in colorectal and gastric cancer. Journal of Surgical Oncology 32 (3), S. 165 - 173 (1986)

Brümmendorf, T.; Anderer, F.; Staab, H.; Hornung, A.; Kieninger, G.: Die Dopplungszeit des zirkulierenden CEA als individuelles prognostisches Kriterium bei Rezidivierung in Patienten mit gastrointestinalen Karzinomen: CEA time courses as an individual prognostic criterion of disease recurrence in patients with gastrointestinal cancer. Wiener Klinische Wochenschrift 64 (2), S. 63 - 69 (1986)

Brümmendorf, T.; Anderer, F.; Staab, H.; Hornung, A.; Kieninger, G.: Carcinoembryonales Antigen: Diagnose der Tumorprogression bei gastrointestinalen Tumoren. Deutsche Medizinische Wochenschrift 110 (51-52), S. 1963 - 1968 (1985)

Orjasaeter, H.; Staab, H.; Heier, H.; Hornung, A.; Kjørstad, K.; Luedin, E.; Rognum, T.; Bell, H.: Comparison of a CEA-EIA assay based on monoclonal antibody with a CEA-RIA assay with polyclonal antiserum. NIPH Annals 8 (1), S. 13 - 26 (1985)

Brümmendorf, T.; Anderer, F.; Staab, H.; Hornung, A.; Stumpf, E.; Kieninger, G.: Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. Journal of Surgical Oncology 28 (4), S. 263 - 269 (1985)

Hollmann, M.; Staab, H.; Spindler, E.; Sproll, M.; Anderer, F.; Fortmeyer, H.: Monoclonal antibody-defined circulating human tumor-associated antigen with epitope shared by cytokeratins. Biochemical and Biophysical Research Communications 128 (1), S. 34 - 39 (1985)

Staab, H.; Anderer, F.; Stumpf, E.; Hornung, A.; Fischer, R.; Kleninger, G.: Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. The American Journal of Surgery 149 (2), S. 198 - 204 (1985)

Staab, H.; Brümmendorf, T.; Hornung, A.; Anderer, F.; Kieninger, G.: The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies. Wiener Klinische Wochenschrift 63 (3), S. 106 - 115 (1985)

Staab, H.; Ahlemann, L.; Anderer, F.; Zwirner, M.; Schindler, A.: Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy control. Cancer Detection and Prevention 8 (1-2), S. 35 - 45 (1985)

Staab, H.; Brümmendorf, T.; Anderer, F.; Hornung, A.; Ahlemann, L.; Kieninger, G.: Differentiation of disease recurrence in various primary malignancies using CEA slope analysis. Tumor Biology 6 (2), S. 157 - 171 (1985)

Kömpf, J.; Staab, H.; Heilbronner, H.; Anderer, F.; Ritter, H.: Cell fusion responsible for horizontal oncogenesis by human tumors in nude mice. Biochemical and Biophysical Research Communications 124 (3), S. 933 - 938 (1984)

Staab, H.; Hornung, A.; Anderer, F.; Kieninger, G.: Klinische Bedeutung des zirkulierenden tumorassoziierten Antigens CA 19-9 bei Karzinomen des Verdauungstraktesantigen (CEA). Deutsche Medizinische Wochenschrift 109 (30), S. 1141 - 1147 (1984)

Staab, H.-J.; Anderer, F.: Immunotherapy of tumor-bearing mice with chemically modified tumor membrane fractions of two syngeneic tumor cell lines. Cancer Detection and Prevention 7 (4), S. 279 - 288 (1984)

Staab, H.; Anderer, F.: Circulating carcinoembryonic antigen (CEA), a growth parameter in malignant disease. Cancer Detection and Prevention 6 (1-2), S. 33 - 39 (1983)

Staab, H.; Anderer, F.; Brümmendorf, T.; Fischer, R.: Prognostic significance of preoperative carcinoembryonic antigen in stomach and colorectal cancer. Cancer Detection and Prevention 6 (1-2), S. 149 - 153 (1983)

Staab, H.; Heilbronner, H.; Schrader, M.; Anderer, F.: In vivo induction of neoplastic growth in nude mouse connective tissue adjacent to xenografted human tumors. Journal of Cancer Research and Clinical Oncology 106 (1), S. 27 - 35 (1983)

Staab, H.; Anderer, F.: Growth of human colonic adenocarcinoma and development of serum CEA in in athymic mice. I: Strict correlation of tumour size and mass with serum CEA concentration during logarithmic growth. British Journal of Cancer 46 (6), S. 841 - 847 (1982)

Staab, H.; Anderer, F.; Hornung, A.; Stumpf, E.; Fischer, R.: Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer. British Journal of Cancer 46 (5), S. 773 - 781 (1982)

Staab, H.; Anderer, F.; Brümmendorf, T.; Hornung, A.; Fischer, R.: Prognostic value of preoperative serum CEA level compared to clinical staging: II. Stomach cancer. British Journal of Cancer 45 (5), S. 718 - 727 (1982)